Pfizer overhaul faces timing dilemma
Article Abstract:
New Chief Executive Officer Jeffrey B. Kindler, Pfizer Inc. of the United States is to institute a restructuring plan. The world's largest pharmaceutical house needs a turnaround for flat sales and dsappointing drug line research results. Sales for the fourth quarter were $12.6 billion.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
J&J profit rises on drug strength, Medicare switch
Article Abstract:
Johnson & Johnson of the United States posted an increase in third quarter profit by 8.7 percent to $2.76 billion. The pharmaceutical company was buoyed by an improved pharmaceutical market, less competition from generic rivals and beneficial results from the Medicare drug insurance.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: How Bristol-Myers fumbled defense of $4 billion drug. Pfizer's strategy takes shape; Europe sales team may be cut deeply; reorganizing R&D
- Abstracts: Profits at European plane makers soar. BAe profit matched expectations in half. Airbus, in a risky bet, to raise production of A320
- Abstracts: An integrated production and inventory model to dampen upstream demand variability in the supply chain. Genetic algorithms for supply-chain scheduling: a case study in the distribution of ready-mixed concrete
- Abstracts: Detailed layout planning for irregularly-shaped machines with transportation path design. Analyzing the effect of the inventory policy on order and inventory variability with linear control theory
- Abstracts: Pirelli Chairman considers reducing Telecom Italia stake. Telecom Italia to unveil plan to modernize